ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 89 filers reported holding ALX ONCOLOGY HLDGS INC in Q4 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $455,000 | -95.0% | 47,586 | -95.8% | 0.00% | -100.0% |
| Q2 2022 | $9,126,000 | -80.8% | 1,128,101 | -59.9% | 0.00% | -75.0% |
| Q1 2022 | $47,486,000 | -40.7% | 2,809,826 | -24.6% | 0.01% | -38.5% |
| Q4 2021 | $80,122,000 | -71.9% | 3,728,330 | -3.6% | 0.01% | -73.5% |
| Q3 2021 | $285,627,000 | +80.3% | 3,867,142 | +33.5% | 0.05% | +88.5% |
| Q2 2021 | $158,402,000 | -19.3% | 2,896,890 | +8.8% | 0.03% | -25.7% |
| Q1 2021 | $196,262,000 | +14.8% | 2,661,562 | +34.2% | 0.04% | +12.9% |
| Q4 2020 | $170,943,000 | +337.8% | 1,983,106 | +91.7% | 0.03% | +287.5% |
| Q3 2020 | $39,042,000 | – | 1,034,528 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $530,392,000 | 62.60% |
| Logos Global Management LP | 3,156,981 | $172,624,000 | 14.51% |
| Vivo Capital, LLC | 4,220,048 | $230,752,000 | 9.99% |
| Foresite Capital Management V, LLC | 231,200 | $12,642,000 | 4.97% |
| Cormorant Asset Management, LP | 889,454 | $48,635,000 | 1.65% |
| Board of Trustees of The Leland Stanford Junior University | 259,982 | $14,216,000 | 1.33% |
| Redmile Group, LLC | 914,035 | $49,979,000 | 0.74% |
| SPHERA FUNDS MANAGEMENT LTD. | 192,728 | $10,538,000 | 0.71% |
| Financial Advisory Group | 54,041 | $2,955,000 | 0.71% |
| Nan Fung Group Holdings Ltd | 34,950 | $1,911,000 | 0.59% |